Zusammenfassung
Das metabolische Syndrom – ein Cluster von Stoffwechselkrankheiten und Hypertonie – ist keine neue Krankheit, sondern lässt sich bereits in allen Hochkulturen bei der Oberschicht mit Nahrungsüberschuss und Bewegungsmangel nachweisen. In der medizinischen Literatur taucht es in der Renaissance- und Barockzeit auf. Gegenwärtig erleben wir einen globalen Tsunami, da Überernährung und Bewegungsmangel typisch für breite Schichten der Bevölkerung geworden sind. Das metabolische Syndrom umfasst in den aktuellen Definitionen der AHA/NHBLI und der IDF das Quartett zentrale Adipositas, erhöhter Blutdruck, erhöhter Blutzucker und Dyslipidämie (Hypertriglyzeridämie, niedriges HDL-Cholesterin). Damit wird eine einfache ganzheitliche Diagnostik und Therapie dieses eng vernetzten Bündels von Krankheiten/Risikofaktoren möglich.
Abstract
Metabolic syndrome – a cluster of metabolic diseases and hypertension – is not a new disease. It has been present in the upper classes of all highly developed cultures suffering from over-nutrition and limited physical activity. In the medical literature, it can be found in Renaissance and Baroque times. We are presently experiencing a global tsunami of this syndrome as over-nutrition and lack of movement are typical for large groups of the population. The current definition of metabolic syndrome of the American Heart Association/National Heart, Lung and Blood Institute and the International Diabetes Federation incorporates the quartet central obesity, hypertension, increased blood sugar and dyslipidemia (hypertriglyceridemia, low HDL cholesterol). Thus, simple, collective diagnostics and therapy for this finely meshed group of diseases together with its risk factors is possible.
Literatur
Maranon G (1922) Über Hypertonie und Zuckerkrankheit. Z Inn Med 43: 169–176
Kylin E (1923) Studien über das Hypertonie-Hyperglykaemie-Hyperurikaemie-Syndrom. Z Inn Med 44: 105–127
Vague J (1956) The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutrition 4: 20–27
Camus JP (1966) Goutte, diabete, hyperlipemie: un trisyndrome metabolique. Rev Rhum Mal Osteoartic 33: 10–14
Avogaro P, Crepaldi G (1965) Essential hyperlipidemia, obesity and diabetes. First meeting of the Association of the Study of Diabetes, Montecatini (Italy)
Jahnke K, Daweke H, Liebermeister H et al. (1969) Hormonal and metabolic aspects of obesity in humans. Proceedings of the 6th Congress of the International Diabetes Federation, J. Östman (Ed). Excerpta Medica Foundation, Amsterdam 37: 1595–1607
Haller H (1977) Epidemiology and associated risk factors of hyperlipoproteinemia. Z Gesamte Inn Med 32: 124–128
Hanefeld M, Leonhardt W (1981) Das metabolische Syndrom. Dt Gesundh Wesen 36: 545–551
Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595–1607
Ferrannini E, Haffner SM, Mitchell BD et al. (1991) Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34: 416–422
Haffner SM, Valdez RA, Hazuda HP et al. (1992) Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41: 715–722
DeFronzo RA, Ferrannini E (1991) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173–194
Björntorp P (1988) Abdominal obesity and the development of non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 4: 615–622
Boden G, Chen X, Ruiz J et al. (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. JCI 93: 2438–2446
McGarry JD (1992) What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258: 766–770
Festa A, Hanley AJ, Tracy RP et al. (2003) Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation 108: 1822–1830
Shanmugam N, Reddy MA, Guha M et al. (2003) High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 52: 1256–1264
Matsuzawa Y, Funahashi, T, Kihara S et al. (2004) Adiponectin and metabolic syndrome. Arteriscler Thromb Vasc Biol 2004 24: 29–33
Yudkin JS, Juhan-Vague I, Hawe E et al.; The HIFMECH Study Group (2004) Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism 53: 852–857
Ridker PM, Buring JE, Cook NR et al. (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107: 391–397
Heiskanen TH, Niskanen LK, Hintikka JJ et al. (2006) Metabolic syndrome and depression: a cross-sectional analysis. J Clin Psychiatry 67: 1422–1427
WHO Consultation (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of Diabetes mellitus. World Health Organisation, Geneva, pp 1–59
Pouliot MC, Despres JP, Nadeau A et al. (1992) Visceral obesity in men: associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41: 826–834
Yusuf S, Hawken S, Ounpuu S et al.; INTERHEART Study Investigators (2005) Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366: 1640–1649
Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (2001) Executive summary of the third report of the National cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). JAMA 285: 2486–2497
Grundy SM, Cleeman JI, Daniels SR et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112: 2735–2752
Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome – a new worldwide definition. Lancet 366: 1059–1062
Diskussions-Entwurf für eine Praxis-Leitlinie Metabolisches Syndrom. Fachkommission Diabetes Sachsen. März 2006
Kahn R, Buse J, Ferrannini E et al.; American Diabetes Association; European Association for the Study of Diabetes (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28: 2289–2304
Gale EA (2005) The myth of the metabolic syndrome. Diabetologia 48: 1679–1683
Hanefeld M, Koehler C, Benke I et al. (2006) Prevalence of the metabolic syndrome and its association with vascular diseases in type 2 diabetes: The Diabetes in Germany (DIG) Study. Diabetes Care: submitted
Koehler C, Ott P, Benke I et al.; the DIG study group (2006) Comparison of the WHO, AHA/NHLBI and IDF definitions of the metabolic syndrome in a German population based study with type 2 diabetes (Abstract). IMS 2006, Dresden
Stern MP (1995) Diabetes and cardiovascular disease: the „common soil“ hypothesis. Diabetes 44: 369–374
Interessenkonflikt
Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hanefeld, M., Schaper, F. & Ceriello, A. Geschichte und Definition(en) des metabolischen Syndroms. Internist 48, 117–125 (2007). https://doi.org/10.1007/s00108-006-1786-5
Issue Date:
DOI: https://doi.org/10.1007/s00108-006-1786-5